Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

Quotient Sciences, Acesion Pharma partner on AI-enhanced formulation for atrial fibrillation small molecules
Research collaboration, AI/ML, small molecule, cardiovascular, drug discovery - Read more

Kairos Pharma expands Ph2 trial of ENV-105 targeting CD105 into earlier castration-resistant prostate cancer setting
Small molecule, cancer, prostate cancer, CD105, androgen receptor inhibitor, combination therapy - Read more

AbbVie, Genmab's Epkinly (epcoritamab) cuts disease progression risk by 51% in Ph3 first-line diffuse large B cell lymphoma
Antibody, cancer, bispecific antibody, diffuse large B cell lymphoma, CD20xCD3, combination therapy - Read more

Epicrispr Biotechnologies shares Ph1/2 data showing EPI-321 (EPI-321) boosts muscle volume in facioscapulohumeral muscular dystrophy patients
Gene therapy, neurological, epigenetic silencing, facioscapulohumeral muscular dystrophy, DUX4, AAV vector - Read more

PharmaBio Corporation's PAL-222 meets Ph1/Ph2a primary endpoint suppressing myopic chorioretinal atrophy expansion
Cell therapy, ophthalmology, mesenchymal stromal cell, chorioretinal atrophy, myopia - Read more

Cell and Gene Live is a one-day, investor & CEO summit dedicated exclusively to Cell and Gene therapy - the science, the manufacturing, and the investment driving advanced medicines forward. All happening on November 15, 2026.

(Hosted by Onyx at The Shard in London as part of London Life Sciences Week)

Speakers confirmed include:

• Steve Bates, OBE (Chair of the UK's Department of Life Sciences)
• Dr. Erik Wiklund (CEO of Circio)
• Edwin Stone (CEO of Cellular Origins)
+ many more!

Get your tickets here - for TLDR Biotech readers, use code ANIS20 at check-out for 20% off.

RougeTx launches with $58M Series A to advance oral RTX-001 into first-in-human trials for hereditary hemorrhagic telangiectasia
Rare disease, small molecule, vascular disease, preclinical, platform technology - Read more

Arboretum LifeSciences launches with $30M Series A to bring genomic precision medicine to common diseases and drug development
Precision medicine, AI/ML platform, genomics, common diseases, biomarker discovery, clinical trial platform - Read more

TRex Bio plans $125M IPO to advance Treg-boosting autoimmune and inflammatory therapies
Autoimmune, regulatory T cells, antibody, Fc-fusion protein, inflammatory disease, clinical-stage - Read more

Forbion raises €2.3B ($2.6B) across two funds to support ~30 high-potential biotechs
Venture capital, biotech investment, gene therapy, small molecule - Read more

Retension Pharmaceuticals plans $40M IPO, developing oral PDE-5 inhibitor for resistant hypertension
Cardiovascular, small molecule, hypertension, clinical-stage - Read more

Rewind Therapeutics secures additional financing to advance oral GPR17 MS remyelination program
Neurological, small molecule, multiple sclerosis, remyelination, preclinical - Read more

Spyre Therapeutics prices $350M public offering to advance immunology programs in gastroenterology, rheumatology, dermatology
Immunology, autoimmune, clinical-stage, antibody, dermatology - Read more

RoslinCT awarded £7.25M ($9.6M) Scottish Enterprise R&D grant to advance digital cell therapy manufacturing
Cell therapy, CDMO, operational, financial - Read more

Serán Bioscience closes undisclosed funding round to accelerate CDMO expansion, commercial facility completion
CDMO, particle engineering, formulation design, manufacturing, analytical services - Read more

SereNeuro Therapeutics closes undisclosed Pre-Seed funding to advance non-opioid pain therapies
Neurological, non-opioid, cell therapy, gene therapy, pain, preclinical - Read more

Consano Bio raises over $15M in financing to expand operations and R&D efforts
Orthopedic, biologic therapy, inflammation, chronic pain - Read more

AstraZeneca opens 570,000-square-foot Kendall Square R&D center housing 2,000 researchers
Cell therapy, oncology, rare disease, operational - Read more

BD pledges $19B U.S. investment, including $3B for manufacturing expansion amid onshoring push
Medical devices, healthcare infrastructure, manufacturing, major transaction - Read more

Shionogi to acquire IntraBio for $2B, gaining rare disease drug Aqneursa approved in two inherited disorders
Small molecule, rare disease, major transaction, strategic - Read more

GE HealthCare acquires Sofie Biosciences for $945M to expand U.S. radiopharmaceutical manufacturing reach
Radiopharmaceutical, medical imaging, strategic, major transaction - Read more

MHRA to continuously monitor AI-based medical devices under new UK regulatory framework
AI medical devices, medtech, regulatory, operational - Read more

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

ArriVent BioPharma's (firmonertinib) Ph3 trial fails primary endpoint in EGFR exon 20 insertion non-small-cell lung cancer
Small molecule, cancer, EGFR inhibitor, non-small cell lung cancer, EGFR exon 20 insertion mutation - Read more

CRB survey finds compliance concerns limiting AI adoption in regulated drug manufacturing to under 10%
AI-enabled manufacturing, drug manufacturing, regulatory, operational, compliance - Read more

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here